Search

Author/Creator Patel, Dhaval M.

1. Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial. Issue 19 (27th April 2016)

Authors:
de Bruyn, Guy; Saleh, Jamshid; Workman, David; Pollak, Richard; Elinoff, Victor; Fraser, Neil J.; Lefebvre, Gigi; Martens, Mark; Mills, Richard E.; Nathan, Richard; Trevino, Miguel; van Cleeff, Martin; Foglia, Ginamarie; Ozol-Godfrey, Ayca; Patel, Dhaval M.; Pietrobon, Patricia J.; Gesser, Richard
Journal:
Vaccine
Issue:
Volume 34:Issue 19(2016)
Page Start:
2170
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Persistence of Hepatitis B Immune Memory Until 6 Years of Age Following Hexavalent DTaP-IPV-HB-PRP~T Vaccination in a 3-, 5- and 11- to 12-month Schedule and Response to a Subsequent Hepatitis B Challenge Vaccination. Issue 1 (January 2021)

Authors:
Virta, Miia; Soininen, Anu; Patel, Dhaval M.; Petit, Céline; Tabar, Cynthia; Lyabis, Olga
Journal:
Pediatric infectious disease journal
Issue:
Volume 40:Issue 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Safety and immunogenicity of Clostridium difficile toxoid vaccine in Japanese adults. Issue 2 (1st February 2018)

Authors:
Matsuoka, Osamu; Patel, Dhaval M.; Sasaki, Shin; Oka, Hayato; Sasaki, Toru; Pietrobon, Patricia J.; Laot, Thelma; Bouckenooghe, Alain; Menezes, Josemund; de Bruyn, Guy
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 14:Issue 2(2018)
Page Start:
322
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗